Approval · Notice of Compliance 15055 · 2013
CORIFACT 250: Notice of Compliance 15055
Issued December 24, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15055
- Date
- December 24, 2013
- Company
- Csl Behring Canada IncOttawa, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Coagulation factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CORIFACT 250 | 02418738 | Marketed |
| CORIFACT 1250 | 02418746 | Marketed |
Medicinal ingredients
- FACTOR XIII (HUMAN) 250 UNIT per VIAL
- FACTOR XIII (HUMAN) 1,250 UNIT per VIAL